CooperVision sponsors Optometry Giving Sight, gets FDA OK for Avaira toric CLs

Article

The Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric 2-week silicone hydrogel contact lenses for astigmatism. The lenses are available for select distribution beginning this month.

Pleasanton, CA-The Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric 2-week silicone hydrogel contact lenses for astigmatism. The lenses are available for select distribution beginning this month.

The company also has made a 2-year commitment to support Optometry Giving Sight as a Platinum Gold Sponsor. The World Council of Optometry, the International Centre created Optometry Giving Sight in 2003 for Eyecare Education and the International Agency for the Prevention of Blindness to mobilize resources from the global optometric community to fund sustainable vision care in underserved areas.

“This is a very significant commitment by our company to an organization that we believe is having a substantial impact on the delivery of sustainable eye care services in underserved communities throughout the world,” CooperVision President John Weber said. “As a global company, we think it makes absolute sense to actively support a global charity, especially one that is doing so much to promote and develop optometry as a respected and recognized profession throughout the world.”

For more articles in this issue of InDispensable, click here.

Recent Videos
Jeffry Gerson, OD, FAAO, overviews a presentation he gave at VEW 2024 on AMD
Ben Casella, OD, FAAO, talks 2024 EyeCon's networking and education opportunities
Mark Dunbar, OD, FAAO, gives overview of advancements in GA treatment
Brianna Rhue, OD, FAAO, FSLS, discusses AI and office technology at Vision Expo West
Brianna Rhue, OD, FAAO, FSLS, talks myopia management at Vision Expo West 2024
Ben Casella, OD, FAAO, giving a reminder for eye care providers to register for EyeCon 2024.
© 2024 MJH Life Sciences

All rights reserved.